References
- Sajjadi H, Paparella MM. Meniere's disease. Lancet 2008;372:406–14.
- Nakashima T, Naganawa S, Sugiura M, Teranishi M, Sone M, Hayashi H, Visualization of endolymphatic hydrops in patients with Meniere's disease. Laryngoscope 2007;117:415–20.
- Naganawa S, Satake H, Kawamura M, Fukatsu H, Sone M, Nakashima T. Separate visualization of endolymphatic space, perilymphatic space and bone by a single pulse sequence; 3D-inversion recovery imaging utilizing real reconstruction after intratympanic Gd-DTPA administration at 3 Tesla. Eur Radiol 2008;18:920–4.
- Naganawa S, Satake H, Iwano S, Fukatsu H, Sone M, Nakashima T. Imaging endolympatic hydrops at 3 Tesla using 3D-FLAIR with intratympanic Gd-DTPA administration. Magn Reson Med Sci 2008;7:85–91.
- Fukuoka H, Tsukada K, Miyagawa M, Oguchi T, Takumi Y, Sugiura M, Semi-quantitative evaluation of endolymphatic hydrops by bilateral intratympanic gadolinium-based contrast agent (GBCA) administration with MRI for Meniere's disease. Acta Otolaryngol 2010;130:10–16.
- Kimura H, Aso S, Watanabe Y. Prediction of progression from atypical to definite Meniere's disease using electrocochleography and glycerol and furosemide tests. Acta Otolaryngol 2003;123:388–95.
- Ito M, Watanabe Y, Shojaku H, Kobayashi H, Aso S, Mizukoshi K. Furosemide VOR test for the detection of endolymphatic hydrops. Acta Otolaryngol Suppl 1993;504:55–7.
- Taguchi D, Kakigi A, Takeda T, Sawada S, Nakatani H. Diagnostic value of plasma antidiuretic hormone, electrocochleography, and glycerol test in patients with endolymphatic hydrops. ORL J Otorhinolaryngol Relat Spec 2009;71(Suppl 1):26–9.
- Miyagawa M, Fukuoka H, Tsukada K, Oguchi T, Takumi Y, Sugiura M, Endolymphatic hydrops and therapeutic effects are visualized in ‘atypical’ Meniere's disease. Acta Otolaryngol 2009;129:1326–9.